K. Lensch

A clinical study of the selective MAO-A-inhibitor moclobemide (Ro 11-1163): a comparison of 2 different dosages with particular reference to platelet MAO-activity and urinary MHPG-excretion.

J. Böning, U. Milech, K. Lensch, 1987, International clinical psychopharmacology.